|
1
|
Chapoval AI, Ni J, Lau JS, Wilcox RA,
Flies DB, Liu D, Dong H, Sica GL, Zhu G, Tamada K and Chen L:
B7-H3: A costimulatory molecule for T cell activation and IFN-gamma
production. Nat Immunol. 2:269–274. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Steinberger P, Majdic O, Derdak SV,
Pfistershammer K, Kirchberger S, Klauser C, Zlabinger G, Pickl WF,
Stöckl J and Knapp W: Molecular characterization of human
4Ig-B7-H3, a member of the B7 family with four Ig-like domains. J
Immunol. 172:2352–2359. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Greenwald RJ, Freeman GJ and Sharpe AH:
The B7 family revisited. Annu Rev Immunol. 23:515–548. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nygren MK, Tekle C, Ingebrigtsen VA,
Mäkelä R, Krohn M, Aure MR, Nunes-Xavier CE, Perälä M, Tramm T,
Alsner J, et al: Identifying microRNAs regulating B7-H3 in breast
cancer: The clinical impact of microRNA-29c. Br J Cancer.
110:2072–2080. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun J, Mao Y, Zhang YQ, Guo YD, Mu CY, Fu
FQ and Zhang XG: Clinical significance of the induction of
macrophage differentiation by the costimulatory molecule B7-H3 in
human non-small cell lung cancer. Oncol Lett. 6:1253–1260.
2013.PubMed/NCBI
|
|
6
|
Crispen PL, Sheinin Y, Roth TJ, Lohse CM,
Kuntz SM, Frigola X, Thompson RH, Boorjian SA, Dong H, Leibovich
BC, et al: Tumor cell and tumor vasculature expression of B7-H3
predict survival in clear cell renal cell carcinoma. Clin Cancer
Res. 14:5150–5157. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Boland JM, Kwon ED, Harrington SM,
Wampfler JA, Tang H, Yang P and Aubry MC: Tumor B7-H1 and B7-H3
expression in squamous cell carcinoma of the lung. Clin Lung
Cancer. 14:157–163. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ingebrigtsen VA, Boye K, Tekle C, Nesland
JM, Flatmark K and Fodstad O: B7-H3 expression in colorectal
cancer: Nuclear localization strongly predicts poor outcome in
colon cancer. Int J Cancer. 131:2528–2536. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tekle C, Nygren MK, Chen YW, Dybsjord I,
Nesland JM, Maelandsmo GM and Fodstad O: B7-H3 contributes to the
metastatic capacity of melanoma cells by modulation of known
metastasis-associated genes. Int J Cancer. 130:2282–2290. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Castriconi R, Dondero A, Augugliaro R,
Cantoni C, Carnemolla B, Sementa AR, Negri F, Conte R, Corrias MV,
Moretta L, et al: Identification of 4Ig-B7-H3 as a
neuroblastoma-associated molecule that exerts a protective role
from an NK cell-mediated lysis. Proc Natl Acad Sci USA.
101:12640–12645. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Imai K, Wilson BS, Bigotti A, Natali PG
and Ferrone S: A 94,000-dalton glycoprotein expressed by human
melanoma and carcinoma cells. J Natl Cancer Inst. 68:761–769.
1982.PubMed/NCBI
|
|
12
|
Chen YW, Tekle C and Fodstad O: The
immunoregulatory protein human B7H3 is a tumor-associated antigen
that regulates tumor cell migration and invasion. Curr Cancer Drug
Targets. 8:404–413. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fauci JM, Sabbatino F, Wang Y,
Londoño-Joshi AI, Straughn JM Jr, Landen CN, Ferrone S and
Buchsbaum DJ: Monoclonal antibody-based immunotherapy of ovarian
cancer: Targeting ovarian cancer cells with the B7-H3-specific mAb
376.96. Gynecol Oncol. 132:203–210. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Roth TJ, Sheinin Y, Lohse CM, Kuntz SM,
Frigola X, Inman BA, Krambeck AE, McKenney ME, Karnes RJ, Blute ML,
et al: B7-H3 ligand expression by prostate cancer: A novel marker
of prognosis and potential target for therapy. Cancer Res.
67:7893–7900. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu CP, Jiang JT, Tan M, Zhu YB, Ji M, Xu
KF, Zhao JM, Zhang GB and Zhang XG: Relationship between
co-stimulatory molecule B7-H3 expression and gastric carcinoma
histology and prognosis. World J Gastroenterol. 12:457–459.
2006.PubMed/NCBI
|
|
16
|
Zhou YH, Chen YJ, Ma ZY, Xu L, Wang Q,
Zhang GB, Xie F, Ge Y, Wang XF and Zhang XG: 4IgB7-H3 is the major
isoform expressed on immunocytes as well as malignant cells. Tissue
Antigens. 70:96–104. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Louis DN, Ohgaki H, Wiestler OD, et al:
The 2007 WHO classification of tumours of the central nervous
system. Acta Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang G, Hou J, Shi J, Yu G, Lu B and
Zhang X: Soluble CD276 (B7-H3) is released from monocytes,
dendritic cells and activated T cells and is detectable in normal
human serum. Immunology. 123:538–546. 2008. View Article : Google Scholar : PubMed/NCBI
|
